Hänel, M <br/><br/>
Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia.  [electronic resource] 

 -  Onkologie  Aug 2001 
 - 356-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0378-584X 
<br/><br/><label>Standard No.: </label>10.1159/000055107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Pilot Projects<br/>Salvage Therapy<br/>Survival Rate<br/>Vidarabine--administration & dosage